425 related articles for article (PubMed ID: 22524830)
1. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
3. Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Zhu XY
Asian Pac J Cancer Prev; 2012; 13(5):1901-6. PubMed ID: 22901144
[TBL] [Abstract][Full Text] [Related]
4. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
5. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
6. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
9. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
[TBL] [Abstract][Full Text] [Related]
10. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
11. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
12. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
Kalinina T; Kononchuk V; Alekseenok E; Obukhova D; Sidorov S; Strunkin D; Gulyaeva L
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33923732
[TBL] [Abstract][Full Text] [Related]
13. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
Eissa S; Matboli M; Shehata HH
Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
[TBL] [Abstract][Full Text] [Related]
15. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
[TBL] [Abstract][Full Text] [Related]
16. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.
Cascione L; Gasparini P; Lovat F; Carasi S; Pulvirenti A; Ferro A; Alder H; He G; Vecchione A; Croce CM; Shapiro CL; Huebner K
PLoS One; 2013; 8(2):e55910. PubMed ID: 23405235
[TBL] [Abstract][Full Text] [Related]
17. MACE-Seq-based coding RNA and TrueQuant-based small RNA profile in breast cancer: tumor-suppressive miRNA-1275 identified as a novel marker.
Majed SO; Mustafa SA
BMC Cancer; 2021 Apr; 21(1):473. PubMed ID: 33910530
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
Marino AL; Evangelista AF; Vieira RA; Macedo T; Kerr LM; Abrahão-Machado LF; Longatto-Filho A; Silveira HC; Marques MM
BMC Cancer; 2014 Oct; 14():739. PubMed ID: 25277099
[TBL] [Abstract][Full Text] [Related]
19. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
[TBL] [Abstract][Full Text] [Related]
20. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
